# Pfizer (PFE) — Analyst Forecast

PFE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/pfe/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 9 | 18 | 2 | 29 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $28.00 | $30.40 | $33.00 | 5 |

Last price $29.44 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 9, 2026 | JP Morgan | Maintained | Neutral | $30.00 |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | $28.00 |
| Oct 6, 2026 | Scotiabank | Maintained | Sector Outperform | $33.00 |
| Sep 10, 2026 | HSBC | Maintained | Hold | $30.00 |
| Aug 7, 2026 | Guggenheim | Maintained | Buy | $31.00 |
| Jul 13, 2026 | Guggenheim | Maintained | Buy | $35.00 |
| Jul 13, 2026 | BMO Capital | Maintained | Outperform | $30.00 |
| Jul 10, 2026 | B of A Securities | Maintained | Neutral | $26.00 |
| Jul 8, 2026 | JP Morgan | Maintained | Neutral | $28.00 |
| Jul 6, 2026 | HSBC | Downgraded | Buy → Hold | $28.00 |
| Jul 6, 2026 | Cantor Fitzgerald | Maintained | Neutral | $27.00 |
| Jun 10, 2026 | RBC Capital | Upgraded | Underperform → Sector Perform | $25.00 |
| Apr 29, 2026 | Citigroup | Maintained | Neutral | $27.00 |
| Apr 20, 2026 | RBC Capital | Maintained | Underperform | $25.00 |
| Apr 16, 2026 | CICC | Initiated Coverage | Outperform | $33.00 |
| Apr 13, 2026 | UBS | Maintained | Neutral | $27.00 |
| Apr 10, 2026 | Morgan Stanley | Maintained | Equal-Weight | $28.00 |
| Apr 9, 2026 | B of A Securities | Maintained | Neutral | $26.00 |
| Mar 24, 2026 | Guggenheim | Maintained | Buy | $36.00 |
| Mar 17, 2026 | HSBC | Maintained | Buy | $32.00 |

## Frequently Asked Questions

### What is the price target for PFE stock?

The average 12-month analyst price target for Pfizer (PFE) is $30.40, with a high estimate of $33.00 and a low of $28.00, across 5 analysts.

### Is PFE a buy, sell, or hold?

Analysts covering Pfizer currently average a Hold rating: 9 buy, 18 hold and 2 sell, from 29 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for PFE?

The average price target of $30.40 implies 3.26% upside from the last price of $29.44.

### What is the latest analyst rating on PFE?

On Oct 9, 2026, JP Morgan maintained Pfizer at Neutral with a price target of $30.00.

## Similar Stocks

- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [NVAX](https://www.lighthorse.io/tickers/nvax) — Novavax, Inc. - Common Stock
- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares
- [BMY](https://www.lighthorse.io/tickers/bmy) — Bristol-Myers Squibb Company Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).